3 min read
Local Infusion Editorial: Nov 2, 2023 9:01:57 AM
Crystal Stevens, Regional Manager at Local Infusion shares with us what it’s like to work on the care team at Local Infusion and how everyone is empowered to do their best work for patients.
3 min read
Local Infusion Editorial: Oct 19, 2023 9:02:19 AM
Local Infusion’s Head of Product Tina Liu opens up about the unique challenges & opportunities in the infusion space, how operations influences technology, and why, at the end of the day, it’s all in service of a better patient experience.
4 min read
.jpg?width=30&name=Ashley%20Knapp%20(1).jpg){kind=small}
Ashley Knapp, RN: Oct 12, 2023 8:30:29 AM
A guide to the best and worst exercises for individuals with Crohn's disease to help improve overall well-being and quality of life.
3 min read
Ashley Knapp, RN: Oct 5, 2023 9:01:10 AM
Although new treatment options have improved the quality of life for RA patients, the disease can still result in long-term joint damage and disability. This is why it’s so important to incorporate the right forms of physical activity alongside treatment.
4 min read
Jenna Paladino, NP: Sep 28, 2023 8:30:11 AM
Foods to eat & trigger foods to avoid in order to feel your best with Crohn’s disease.
3 min read
Jenna Paladino, NP: Sep 21, 2023 8:32:47 AM
How much infusions of this new Alzheimer’s drug cost (with and without insurance) and how patients can lower the cost.
6 min read
Jenna Paladino, NP: Sep 7, 2023 8:30:25 AM
Living with rheumatoid arthritis (RA) can present unique challenges, but making informed choices about what you eat can have a significant impact on managing your symptoms and overall well-being.
5 min read
Jenna Paladino, NP: Aug 31, 2023 8:30:41 AM
Dive into the differences between Leqembi (lecanemab) & Donanemab to better determine which is best for you.
5 min read
Jenna Paladino, NP: Aug 24, 2023 8:30:13 AM
Discover the differences between these two drugs to better determine which is best for you.
4 min read
Jenna Paladino, NP: Aug 17, 2023 8:29:58 AM
The FDA’s full approval of Leqembi (lecanemab-irmb) has made it one of the few infusions that can be used for Alzheimer’s disease.
